Highlights Chordate Medical Holding AB

Equities

CMH

SE0009495559

Market Closed - Nasdaq Stockholm Other stock markets 11:29:45 2024-05-31 am EDT			5-day change	1st Jan Change
0.0522 ^SEK	-2.97%		+6.10%	-67.46%

May. 24	Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 07	Chordate Medical Receives Patent Approval in the US	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 24	CI
Chordate Medical Receives Patent Approval in the US	May. 07	CI
Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 22	CI
Chordate Medical Gains EU Patent for Chronic Migraine Treatment	Feb. 02	MT
Chordate Medical Holding AB Announces the European Patent Office Grants New Patent	Feb. 02	CI
Chordate Medical Holding AB Signs Agreement with German Clinic for the Ozilia Treatment for Chronic Migraine	Jan. 30	CI
Chordate Medical Completes Training of Clinic Staff and Assists in Initiation of Treatment for First Three Patients at the Private Clinic in Hamburg	Jan. 10	CI
Chordate Medical Holding AB Announces First Patients Included in the Post-Market Study PM010	Dec. 21	CI
Chordate Medical Holding AB Announces First Patient Included in the Company's Open Pilot Study PM009	Dec. 04	CI
Chordate Medical Holding AB Receives First Installation of the Ozilia Migraine Treatment at a Private Clinic in Hamburg	Nov. 28	CI
Chordate Medical Holding AB Announces Post-Market Study of Chordate's Ozilia® Migraine Treatment Has Commenced in Four Different Markets	Nov. 10	CI
Chordate Medical Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Oct. 31	CI
Chordate Medical Trademarks Migraine Treatment Ozilia in EU	23-10-27	MT
Chordate Medical Receives Registration of the Tradark Ozilia	23-10-27	CI
Chordate Medical Holding AB Introduces New Trademark for Migraine Treatment: Ozilia? - Migraine Relief	23-09-11	CI
Chordate Medical Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-30	CI
Chordate Medical Holding AB Announces Complete Study Results from Migraine Study Submitted to Scientific Journal	23-08-21	CI
Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
UK's National Health Service Grants Ethical Approval for Chordate Medical Migraine Study	23-05-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Chordate Medical Holding AB

Equities

CMH

SE0009495559

Highlights

Filters